Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Leading pharmaceutical companies: world market share 2010

Market share of some leading pharmaceutical companies worldwide in 2010

by Statista Research Department, last edited Jun 10, 2011
Leading pharmaceutical companies: world market share 2010 This statistic shows the market share of some leading pharmaceutical companies worldwide in 2010. In that year, German pharmaceutical company Merck had a 0.8 percent share of the world market.
Show more

Market share of some leading pharmaceutical companies worldwide in 2010

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Novartis"
  • Global positioning
The most important statistics
  • Company overview
  • Revenue distribution
  • Research and development
  • Miscellaneous
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: You might find this interesting as well
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.